Asklepios Klinik St.Georg

Hamburg D-20099

2 studies enrolling now · 31 studies all time

What they study most

Acute Coronary Syndrome, Acute Myeloid Leukemia, Arrhythmia, Atrial Fibrillation, Autologous Stem Cell Transplant, Colorectal Cancer Stage II, Colorectal Cancer Stage III, Coronary Artery Disease, Diabetes Mellitus, Type 2, Extrapulmonary Neuroendocrine Cancer (epNEC), Gaucher Disease, Type 1, Heart Failure

Studies at this site

• DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy — Recruiting now
• Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS — Recruiting now
• Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome — Running, not enrolling
• A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination — Paused
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy — Completed
• AMPLATZER™ Amulet™ LAA Occluder Trial — Completed
• Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF — Completed
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection — Stopped early
• SUrgical Versus PERcutaneous AXillary Artery International Registry — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma — Completed
• Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial — Completed
• Multicenter Imaging in Lead Extraction Study — Completed
• First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study) — Completed
• A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN) — Completed
• Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• FREEZE Cohort Study — Completed
• Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC) — Completed
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed
• DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation — Completed
• A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE) — Completed
• ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen — Status unconfirmed
• Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients — Stopped early
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early